ENTITY
Pacific Edge

Pacific Edge (PEB NZ)

67
Analysis
Health Care • New Zealand
Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. The Company has completed successful trials in bladder cancer detection and colorectal cancer prognosis.
more
bullish•Pacific Edge
•02 Dec 2021 08:40•Broker

Pacific Edge (PEB): 1H22 Result – Initial Impressions

Pacific Edge (PEB)1H22 Result – Initial Impressions Pacific Edge (PEB) reported a 1H22 NPAT loss of -NZ$9.0m, which was +NZ$0.4m better than our...

Logo
1.2k Views
Share
•20 Oct 2021 08:05•Broker

Company Coverage: Temporary Analyst Change

Company Coverage Temporary Analyst Change  We temporarily transfer coverage of the following companies to Matt Montgomerie due to...

Logo
404 Views
Share
bullish•Pacific Edge
•01 Oct 2021 08:03•Broker

Pacific Edge: Capital Raise

Pacific EdgeCapital Raise RESTRICTED Pacific Edge (PEB) has announced a capital raise, totalling up to NZ$80m, to accelerate execution of its...

Logo
1.4k Views
Share
bullish•Pacific Edge
•30 Sep 2021 08:09•Broker

Pacific Edge: Capital Raising

Pacific EdgeCapital Raising Pacific Edge (PEB) has announced a capital raise, totalling up to NZ$80m, to accelerate execution of its growth plans....

Logo
1.4k Views
Share
bullish•Pacific Edge
•27 Jul 2021 21:46•Issuer-paid

Pacific Edge - Termination of coverage

Edison Investment Research is terminating coverage on Kcell Joint Stock Company (KCEL), Locate Bio, Pacific Edge (PEB), Tungsten Corporation (TUNG)...

Share
x